INTACEPT 50 INJ VIAL

About

Intacept (Etanercept) is a dimeric fusion protein that acts as a tumor necrosis factor (TNF) inhibitor. It works by binding to TNF-alpha, a cytokine involved in inflammatory and immune responses, thereby preventing TNF-alpha from binding to its receptors on cell surfaces. This action reduces the inflammatory cascade and immune-mediated tissue damage characteristic of various autoimmune diseases. Etanercept is administered subcutaneously and has a prolonged half-life, allowing for once or twice weekly dosing. Its mechanism of action makes it effective in modulating the immune system to alleviate symptoms and slow disease progression in chronic inflammatory conditions.

Uses

• Management of moderate to severe Rheumatoid Arthritis.
• Treatment of Psoriatic Arthritis.
• Management of Ankylosing Spondylitis.
• Treatment of moderate to severe Plaque Psoriasis.

Directions For Use

Administer subcutaneously once or twice weekly as prescribed by your doctor. Ensure proper injection technique and site rotation.

Benefits

• Reduces joint pain and swelling.
• Slows progression of joint damage.
• Improves physical function and quality of life.
• Clears skin lesions in psoriasis.
• Decreases systemic inflammation.
• Provides long-term disease control.

Side Effects

• Injection site reactions (pain, redness, swelling)
• Upper respiratory tract infections
• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Rash
• Dizziness
• Fever
• Increased risk of serious infections (e.g., tuberculosis)
• Heart failure exacerbation
• Demyelinating disorders (rare)

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol can worsen liver function, which might be a concern in some autoimmune conditions.
• Pregnancy - Use during pregnancy is generally not recommended unless clearly necessary, as data on human pregnancy outcomes are limited.
• Breastfeeding - It is unknown if etanercept is excreted in human milk; caution is advised, and a physician should be consulted.
• Liver - Use with caution in patients with pre-existing liver conditions; monitor liver function tests periodically.
• Kidney - No specific dose adjustment required for renal impairment, but caution is advised in severe cases.
• Lung - Increased risk of serious infections, including tuberculosis and other opportunistic infections, which can affect the lungs. Screen for latent TB before starting.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.